• / Free eNewsletters & Magazine
  • / My Account
Home>Stocks>InterCept

InterCept

  1. All
  2. 3rd Party
  1. Johnson & Johnson Announces Encouraging First-in-Human Clinical Data for Investigational HIV Preventive Vaccine

    Johnson & Johnson Announces Encouraging First-in-Human Clinical Data for Investigational HIV Preventive Vaccine

  2. Cerus to Release Second Quarter 2017 Results on August 3, 2017

    Cerus to Release Second Quarter 2017 Results on August 3, 2017

  3. Janssen Receives Positive CHMP Opinion for SYMTUZA™ The First Darunavir-Based Single-Tablet Regimen for the Treatment of HIV

    Janssen Receives Positive CHMP Opinion for SYMTUZA™ The First Darunavir-Based Single-Tablet Regimen for the Treatment of HIV

  4. Global Hypersonic Missiles Market - Analysis, Technologies & Forecasts to 2021 - Latest Trend Gaining Momentum is Emergence of Scramjet Technology - Research and Markets

    Global Hypersonic Missiles Market - Analysis, Technologies & Forecasts to 2021 - Latest Trend Gaining Momentum is Emergence of Scramjet Technology - Research and Markets

  5. Cambridge BioMarketing Honored with Multiple Industry Recognitions

    Cambridge BioMarketing Honored with Multiple Industry Recognitions

  6. UPDATE: This is how many robocalls Americans received last month (and how to prevent them)

    UPDATE: This is how many robocalls Americans received last month (and how to prevent them)

  7. North Korean Money-Laundering Probe Focuses on U.S. Bank Transactions

    North Korean Money-Laundering Probe Focuses on U.S. Bank Transactions

12345

©2017 Morningstar Advisor. All right reserved.